Alyteserin-2a-Sp4

General Information


DRACP ID  DRACP05879

Peptide Name   Alyteserin-2a-Sp4

Sequence  ILGKLLⓍTAAGLLⓍNL

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=8.5±1.4 μM CCK-8 assay 72 h 1
U87 Glioblastoma Blastoma IC50=10.1±1.6 μM CCK-8 assay 72 h 1
A549 Lung adenocarcinoma Carcinoma IC50=11.6±2.2 μM CCK-8 assay 72 h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=9.2μM CCK-8 assay 72h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  51

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ(7) and Ⓧ (14) are cross-linked by hydrocarbon stapling

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  Ⓧ(7)=(R)-2-(7-octenyl)alanine; Ⓧ(14)=(S)-2-(4-pentenyl)alanine

Chiral  L



Physicochemical Information


Formula  C66H116N16O15

Absent amino acids  CDEFHMPQRSVWY

Common amino acids  L

Mass  164151

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  9

Net charge  1

Boman Index  2518

Hydrophobicity  137.5

Aliphatic Index  183.13

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34989078

Title  Hydrocarbon stapling modification of peptide alyteserin-2a: Discovery of novel stapled peptide antitumor agents

Doi 10.1002/psc.3401

Year  2022

Patent

Patent ID CN115160406A

Patent Title  Preparation method and application of novel anti-tumor cyclic peptide active molecules

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.